Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
人体におけるエストロゲン産生の選択的阻害およびエストロゲン作用の提供
Document Type and Number:
Japanese Patent JP2007524599
Kind Code:
A
Abstract:
Implementation is directed to selectively inhibiting estrogen production and providing estrogenic effects in a human body. A dietary supplement includes a processed Morinda citrifolia product that is used to inhibit aromatase or aromatase enzymes that function to convert androgens to estrogens, inhibit receptors from binding with estrogen, and reduce and/or regulate estrogen production, as well as reduce the amount of estrogen produced within the body and regulating such production. The dietary supplement further provides estrogenic effects. The present invention methods and compositions effectively function to treat estrogen-dependent cancers, and particularly inhibit, destroy, and reverse the effects of of estrogen-dependent cancerous tumors through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed Morinda citrifolia products for a safe, pre-determined duration.

Inventors:
Pal, Afa, Keherty
One, Mian, Inn
Sue, Chen, Shin
West, Brett, Justin
Westendorf, Johannes, Joseph
Jensen, Claude, Jarakae
Story, steven, paul
Application Number:
JP2006509279A
Publication Date:
August 30, 2007
Filing Date:
March 25, 2004
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Tahitian Noni International Inc.
Pal, Afa, Keherty
International Classes:
A61K36/18; A23L1/30; A61K31/353; A61K36/00; A61K36/746; A61P5/30; A61P5/32; A61P19/10; A61P25/06; A61P25/26; A61P35/00; A61P43/00
Attorney, Agent or Firm:
Reiko Tanaka
Hitoshi Nakamura